Antibody-Drug Conjugates

Reducing ADC Development Timelines with Integrated Development and Manufacturing Services

Thomas Rohrer

Samsung Biologics

Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

CRB

Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Danielle Alvarez

Pharma's Almanac

Opioid Conjugate Vaccines

Vaccines Present a Novel Strategy for Opioid Overdose Prevention

Muctarr Sesay, Ph.D.

GBI

ADCS

Improving the Therapeutic Index of ADCs with a Peptide Linker Technology

Philipp Spycher

Araris Biotech

Antibody-Drug Conjugates

Accelerating ADC Development with Advanced Payload Intermediates

David Goeddel, Ph.D.

MilliporeSigma

Antibody–Drug Conjugates

Preparing for the ADC Explosion with End-to-End Support

Jyothi Swamy, Ph.D.; Elizabeth McKee

MilliporeSigma

Expansion

MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

Life Science Business of Merck KGaA, Darmstadt, Germany

Collaboration

AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate

AstraZeneca

Antibody–Drug Conjugates

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Loretta Itri, M.D., F.A.C.P.,; Usama Malik

Immunomedics

Licensing

Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs

Five Prime Therapeutics

Antibody-Drug Conjugate

Fast-Tracking ADC Development and Commercialization

Matteo Piazza

PROVEO

Antibody-Drug Conjugate

Increasing the Potency of Antibody–Drug Conjugates

Philipp Spycher

Araris Biotech

Financing

Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million

Araris Biotech AG

FDA Approval

Genetech’s Antibody–Drug Conjugate Receives FDA Approval

David Alvaro, Ph.D.

Pharma's Almanac

Antibody-Drug Conjugate

Integrating ADC Manufacturing for the Future

Mark Frigerio, Ph.D.; Juan Carlos Cordova, Ph.D.

Abzena

ADC

Speeding up ADC Development With the Right Partner Organization

Courtney Morgret, Ph.D.

AbbVie Contract Manufacturing

Antibody-Drug Conjugates

Rapid Growth in the ADC Market Drives Strategic Partnership Interest

Allan Davidson

Piramal Pharma Solutions

ADC

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

Ajinomoto Bio-Pharma Services

FDA Approval

Alteogen Gets FDA Approval for Orphan Drug Designation with an Antibody-Drug Conjugate for Gastric Cancer

Alteogen